INSM
Insmed Incorporated
$95.80
-$2.65(-2.69%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
23.38M
52W Range
$90.39 - $212.75
Target Price
--
Company Overview
| Mkt Cap | -- | Price | $95.80 |
| Volume | 23.38M | Change | -2.69% |
| P/E Ratio | -- | Open | $100.11 |
| Revenue | $606.4M | Prev Close | $98.45 |
| Net Income | $-1.3B | 52W Range | $90.39 - $212.75 |
| Div Yield | N/A | Target | -- |
No chart data available
Latest News
Insmed’s New TPIP Liver Study Marks a Small but Important De‑Risking Step
TipRanks Clinical-Trials-Auto-Generated Newsdesk•10 days ago
Insmed’s New TPIP Liver Study Marks a Small but Important De‑Risking Step
TipRanks Clinical-Trials-Auto-Generated Newsdesk•10 days ago
Insmed Advances Phase 3 Inhaled PAH Therapy, Keeping Growth Hopes Alive
TipRanks Clinical-Trials-Auto-Generated Newsdesk•11 days ago
Invesco QQQ Trust ETF (QQQ) Rebounds from Last Week’s Slump; What’s Fueling the Rise?
Sirisha Bhogaraju•13 days ago
Invesco QQQ Trust ETF (QQQ) Rebounds from Last Week’s Slump; What’s Fueling the Rise?
Sirisha Bhogaraju•13 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INSM | $95.80 | -2.7% | 23.38M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |